Latest Articles
Faeth Therapeutics: $25 Million Raised To Advance PIKTOR Phase 2 Trial Following 80% Response Rate In Endometrial Cancer - Pulse 2.0
Faeth Therapeutics: $25 Million Raised To Advance PIKTOR Phase 2 Trial Following 80% Response Rate In Endometrial Cancer Pulse 2.0
Published: Oct. 20, 2025, 3:54 p.m.
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in E - PharmiWeb.com
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in E PharmiWeb.com
Published: Oct. 20, 2025, 3:02 p.m.
Faeth Therapeutics Raises $25 Million, Reports Phase 2 Results in Ovarian and Endometrial Cancer - Femtech Insider
Faeth Therapeutics Raises $25 Million, Reports Phase 2 Results in Ovarian and Endometrial Cancer Femtech Insider
Published: Oct. 20, 2025, 2:27 p.m.
Faeth Therapeutics’ $92 Million Total Funding Powers PIKTOR Phase 2 - citybiz
Faeth Therapeutics’ $92 Million Total Funding Powers PIKTOR Phase 2 citybiz
Published: Oct. 20, 2025, 1:40 p.m.
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - Business Wire
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer Business Wire
Published: Oct. 20, 2025, noon
Knight Therapeutics Announces Relaunch of MYFEMBREE® in Canada - GlobeNewswire
Knight Therapeutics Announces Relaunch of MYFEMBREE® in Canada GlobeNewswire
Published: Oct. 7, 2025, 9:08 p.m.
United States Endometriosis Therapeutics Market Growth Fueled - openPR.com
United States Endometriosis Therapeutics Market Growth Fueled openPR.com
Published: Sept. 29, 2025, 7:26 a.m.
What to expect from Karyopharm Therapeutics Inc. in the next 30 days - Watch List & Stepwise Trade Signal Guides - newser.com
What to expect from Karyopharm Therapeutics Inc. in the next 30 days - Watch List & Stepwise Trade Signal Guides newser.com
Published: Sept. 22, 2025, 7:20 a.m.
EndoCyclic Therapeutics Awarded Rare NIH "Perfect 10" Grant for Endometriosis Therapeutic - BioSpace
EndoCyclic Therapeutics Awarded Rare NIH "Perfect 10" Grant for Endometriosis Therapeutic BioSpace
Published: Sept. 17, 2025, 7:44 a.m.
EndoCyclic Therapeutics Awarded Rare NIH "Perfect 10" Grant for Endometriosis Therapeutic - biospace.com
EndoCyclic Therapeutics Awarded Rare NIH "Perfect 10" Grant for Endometriosis Therapeutic biospace.com
Published: Sept. 17, 2025, 7:44 a.m.
Link copied to clipboard!